BCM
KALA icon

Bridgeway Capital Management’s KALA BIO KALA Stock Holding History

Bridgeway Capital Management’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-70
Closed -$242K – 1359
2022
Q1 		$242K Buy
+70
New +$183K ﹤0.01% 1134
2020
Q1 		– Sell
-63
Closed -$579K – 1319
2019
Q4 		$579K Hold
63
– – 0.01% 916
2019
Q3 		$597K Buy
63
+8
+15% +$97.4K 0.01% 876
2019
Q2 		$880K Hold
55
– – 0.01% 778
2019
Q1 		$1.14M Buy
55
+21
+62% +$373K 0.01% 713
2018
Q4 		$416K Hold
34
– – 0.01% 1054
2018
Q3 		$839K Buy
+34
New +$1.04M 0.01% 964

Other funds holding KALA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Bridgeway Capital Management's KALA Position: Q2 2022 in Review

Bridgeway Capital Management sold out of KALA BIO (KALA) in Q2 2022, closing a stake of 70 shares — an estimated $242K sold.

Bridgeway Capital Management first reported a position in KALA in Q3 2018 and held it in 7 quarters. The position peaked at $1.14M in Q1 2019. 63 funds tracked by Wall St. Rank hold KALA as of Q2 2022.

  • Bridgeway Capital Management reported no remaining KALA BIO position as of Q2 2022 after selling out during the quarter.
  • Bridgeway Capital Management sold 70 KALA BIO shares in Q2 2022, an estimated $242K.
  • Bridgeway Capital Management first reported a position in KALA BIO in Q3 2018 and held it in 7 quarters.
  • Bridgeway Capital Management's KALA BIO position peaked at $1.14M in Q1 2019.
  • 63 funds tracked by Wall St. Rank held KALA BIO as of Q2 2022.

Based on Bridgeway Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.